Plasmin effects

Rosin is commonly modified with maleic or fumaric acid to improve efficiency. Since the 1970s, dispersions of unsaponifted rosin have become more popular as a result of their improved sizing efficiency, lower alum requirements, and reduced pH sensitivity vs saponified rosins. Cationic dispersed rosin size, which can be effective at near-neutral and neutral papermaking conditions, is also available (63—65). Commercially available rosin sizes include Pexol, Neuphor, and Hi-pHase (Hercules Inc.), Plasmine and NeuRos (Plasmine), Stafor (Westvaco), Novaplus, and Novasize (Georgia Pacific), and NeuRos and Roscol (Akzo Nobel). 

Fibrinolytics. Figure 3 Plasminogen activation (a) Kinetics of plasminogen activation by uPA (urokinase-type) and tPA (tissue-type) plasminogen activators. Effect of fibrin (b) Ternary complex formation between enzyme (tPA), substrate (Pg) and cofactor (F) Abbreviations plasmin (P), fibrin (F), plasminogen (Pg). Plasmin, formed in time, is expressed in arbitrary units. 

Fibrinolytics. Figure 4 Inactivation of plasmin by a2-plasmin inhibitor Effect of fibrin. The inactivation rate of free plasmin is very rapid (the second order rate constant k 430 104M-1s-1), while of fibrin bound plasmin is slow (the second order rate constant k 1 104M"1s"1). Inactivation of plasmin in the figure is shown in arbitrary units. Abbreviations plasmin (P), fibrin (F). 

Transition state theory, 46,208 Transmission factor, 42,44-46,45 Triosephosphate isomerase, 210 Trypsin, 170. See also Trypsin enzyme family active site of, 181 activity of, steric effects on, 210 potential surfaces for, 180 Ser 195-His 57 proton transfer in, 146, 147 specificity of, 171 transition state of, 226 Trypsin enzyme family, catalysis of amide hydrolysis, 170-171. See also Chymotrypsin Elastase Thrombin Trypsin Plasmin Tryptophan, structure of, 110... 

Microplasmin is a truncated form of plasmin that is more resistant to the effects of antiplasmin. In a rabbit stroke model, intravenous microplasmin infusion resulted in a high rate of clot lysis without increasing the rate of ICH. In addition, there was significant improvement in the behavioral rating scores, suggesting a neu-roprotective effect. The ongoing MITI-IV trial is a 40-patient multicenter, double-blind, placebo-controlled trial using three different intravenous doses of microplas-min to treat acute ischemic stroke (NIHSS >6 and <22) within 12 hours of symptom onset. 

A plasmin inhibitor such as aprotinin used for blood collection, while effective in inhibiting activation of plasminogen by urokinase, is ineffective against the ac-... 

Vitamin E supplementation has been shown to have positive effects on milk quality in a conventional commercial dairy herd. Milk obtained from cows that received supplemental vitamin E had lower somatic cell counts and plasmin concentrations than corresponding values in milk obtained from control cows. The reduction in plasmin as a result of vitamin E supplementation is very beneficial to the dairy industry because plasmin reduces the cheese-yielding capacity of milk, affects the coagulating properties of milk and its overall ability to withstand processing during cheesemaking (Politis et al., 2004). 

Politis I, Bizelis I, Tsiaras A and Baldi A (2004), Effect of vitamin E supplementation on neutrophil function, milk composition and plasmin activity in dairy cows in a commercial herd , Journal of Dairy Research, 71, 273-278. 

Streptokinase induces its thrombolytic effect by binding specifically and tightly to plasminogen. This induces a conformational change in the plasminogen molecule that renders it proteolytically active. In this way, the streptokinase-plasminogen complex catalyses the proteolytic conversion of plasminogen to active plasmin. 

The hypothesis that stress can modulate MMP expression is also supported by studies in mice. Using social isolation as a stressor, the mRNA levels of MMP-2, MMP-9, matrix-type matrix metalloproteinase-1 (MT1-MMP), and urokinase-type plasminogen activator were higher in the tumor and liver tissues of the isolated mice than in control mice.91 Furthermore, a recent study has shown that restraint stress causes an increase in expression of the plasminogen activator inhibitor-1, another key player in the plas-minogen/plasmin enzyme system in mice.92 As these enzymes have been described to have functions besides their role in ECM remodeling,93 studies on stress-related effects on MMP/TIMP balance have implications in the relationship between stress and cancer initiation and progression.. 

A series of indolizidinones 274-278 were designed and synthesized to evaluate their inhibitory effect on Factor VILA (FVIIa) in comparison to thrombin (Factor Ha (Flla)), plasmin, and FXIa <2002BML2907>. 

Grainger (G20) reports that Lp(a) promotes proliferation of human smooth muscle cells by inhibition of the activation of plasminogen and activating effect of plasmin on latent transforming growth factor-(3. 

The effects of Lp(a) on the fibrinolytic system are based on the homology between plasminogen and Lp(a) (E3, E5, K4). Inactive Glu-plasminogen is converted to inactive glutamine-plasmin or inactive lysine-plasmin. Both can be converted to active lysine-plasmin, the activity of which is based on the serine protease part that splits fibrin and fibrinogen, but also factors V and Villa. In addition, Lp(a) is able to activate factor XII, factor VII, and the complement factors Cl and C3. 

E2. Eekhout, Y., and Vaes, G., Further studies on the activation of procollagenase, the latest precursor of bone collagenase Effects of lysosomal cathepsin B. plasmin and kallikrein and spontaneous activation. Biochem. J. 36, 1555-1563 (1977). 

The mechanisms of the influence of the SNS on the induction of CD8+ Tregs are likely directed towards both the activation and function of these cells (fig. 2). Sympathetic neurons are a source of (i) norepinephrine that has strong immunoregulatory effects [35] including the proliferation of liver NKT cells necessary for the initiation of contact sensitivity reactions (ii) immunomodulatory NPY [38] that may promote the production of IFN-y necessary for the function of CD8+ suppressor T cells (see below), and (hi) tissue plasminogen activator (t-PA) [41] that converts plasminogen to plasmin that in turn is an activator of immunosuppressive TGF-(3 [42]. 

Plasminogen, an inactive precursor, is activated to plasmin which as a protease is able to break down fibrin clots. The thrombolytic agents in use promote the conversion of plasminogen to plasmin at the site of a thrombus. Indications include post-myocardial infarction treatment. The thrombolytic must be administered within 6 hours for an optimal effect. Other indications are treatment of acute pulmonary thromboembolism, deep-vein thrombosis, acute arterial thrombosis and thromboembolism, as well as in the clearance of arteriovenous catheters and can-nulae. Agents are streptokinase, anistreplase, urokinase, alteplase, reteplase and tenecteplase. 

Cardiopulmonary bypass, with extracorporeal circulation during cardiac artery bypass graft or heart valve replacement surgery, causes transient hemostatic defects in blood cells and perioperative bleeding. The protease inhibitor aprotinin (Trasylol) inhibits kalhkrein (coagulation phase) and plasmin (hbrinolysis) and protects platelets from mechanical injury. The overall effect after infusion is a decrease in bleeding. 

Mechanism of Action A tissue plasminogen activator that activates the fibrinolytic system by directly cleaving plasminogen to generate plasmin, an enzyme that degrades the fibrin ot the thrombus. Therapeutic Effect Exerts CV-thrombolytic action. Pharmacokinetics Rapidlycleared from plasma. Eliminated primarilyby the liverand kidney. Haif-Hfe 13-16 min. 

Mechanism of Action An enzyme that activates the fibrinolytic system by converting plasminogen to plasmin, an enzyme that degrades fibrin clots. Acts indirectlybyform ing a complex with plasminogen, which converts plasminogen to plasmin. Action oc-curs within the thrombus, on its surface, and in circulating blood. Therapeutic Effect Destroys thrombi. 

---